Lataa...
The Role of PPARγ in the Transcriptional Control by Agonists and Antagonists
In recent years, peroxisome proliferator-activated receptor gamma (PPARγ) has been reported to be a target for the treatment of type II diabetes. Furthermore, it has received attention for its therapeutic potential in many other human diseases, including atherosclerosis, obesity, and cancers. Recent...
Tallennettuna:
Päätekijä: | |
---|---|
Aineistotyyppi: | Artigo |
Kieli: | Inglês |
Julkaistu: |
Hindawi Publishing Corporation
2012
|
Aiheet: | |
Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3368591/ https://ncbi.nlm.nih.gov/pubmed/22693486 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/362361 |
Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|